348 related articles for article (PubMed ID: 34151546)
1. Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction.
Sunaga A; Hikoso S; Yamada T; Yasumura Y; Uematsu M; Tamaki S; Abe H; Nakagawa Y; Higuchi Y; Fuji H; Mano T; Kurakami H; Yamada T; Kitamura T; Sato T; Oeun B; Kida H; Kojima T; Sotomi Y; Dohi T; Okada K; Suna S; Mizuno H; Nakatani D; Sakata Y;
ESC Heart Fail; 2021 Aug; 8(4):3316-3326. PubMed ID: 34151546
[TBL] [Abstract][Full Text] [Related]
2. β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction.
Hikoso S; Kida H; Sunaga A; Nakatani D; Okada K; Dohi T; Sotomi Y; Oeun B; Sato T; Matsuoka Y; Kitamura T; Yamada T; Kurakami H; Tamaki S; Seo M; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Yamada T; Yasumura Y; Sakata Y;
Clin Res Cardiol; 2024 Jun; 113(6):842-855. PubMed ID: 38019285
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry.
Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Tamaki S; Yano M; Hayashi T; Nakagawa Y; Yamada T; Nakatani D; Hikoso S; Sakata Y;
BMC Cardiovasc Disord; 2021 Jun; 21(1):281. PubMed ID: 34098878
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognosis of frailty in older patients with stage B heart failure with preserved ejection fraction.
Meng C; Chai K; Li YY; Luo Y; Wang H; Yang JF
ESC Heart Fail; 2023 Apr; 10(2):1133-1143. PubMed ID: 36601690
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fraction.
Sotomi Y; Iwakura K; Hikoso S; Inoue K; Onishi T; Okada M; Fujii K; Okamura A; Tamaki S; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Nakatani D; Yasumura Y; Yamada T; Sakata Y;
ESC Heart Fail; 2021 Jun; 8(3):2154-2164. PubMed ID: 33760383
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
8. Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
Nishino M; Egami Y; Kawanami S; Sugae H; Ukita K; Kawamura A; Nakamura H; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Yano M; Tanouchi J; Yamada T; Yasumura Y; Seo M; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
Int J Cardiol; 2023 May; 378():55-63. PubMed ID: 36796493
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Echocardiographic Diastolic Dysfunction on Outcomes in Patients With Heart Failure With Preserved Ejection Fraction - Insights From the PURSUIT-HFpEF Registry.
Oeun B; Hikoso S; Nakatani D; Mizuno H; Suna S; Kitamura T; Okada K; Dohi T; Sotomi Y; Kojima T; Kida H; Sunaga A; Sato T; Takeda Y; Kurakami H; Yamada T; Tamaki S; Abe H; Nakagawa Y; Higuchi Y; Fuji H; Mano T; Uematsu M; Yasumura Y; Yamada T; Sakata Y;
Circ J; 2021 Dec; 86(1):23-33. PubMed ID: 34456213
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry.
Oeun B; Hikoso S; Nakatani D; Mizuno H; Suna S; Kitamura T; Okada K; Dohi T; Sotomi Y; Kida H; Sunaga A; Sato T; Nakagawa A; Nakagawa Y; Hayashi T; Yano M; Tamaki S; Yasumura Y; Yamada T; Sakata Y;
BMJ Open; 2021 Sep; 11(9):e049371. PubMed ID: 34526341
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
12. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
[No Abstract] [Full Text] [Related]
13. Prognostic significance of serum chloride level in heart failure patients with preserved ejection fraction.
Seo M; Watanabe T; Yamada T; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Tamaki S; Yasumura Y; Sotomi Y; Hikoso S; Nakatani D; Fukunami M; Sakata Y;
ESC Heart Fail; 2022 Apr; 9(2):1444-1453. PubMed ID: 35137570
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of heart failure with recovered ejection fraction].
Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
[No Abstract] [Full Text] [Related]
15. Impact of admission hyperglycaemia on clinical outcomes in non-diabetic heart failure with preserved ejection fraction.
Yano M; Nishino M; Ukita K; Kawamura A; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Matsunaga-Lee Y; Egami Y; Shutta R; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Dohi T; Nakatani D; Hikoso S; Sakata Y;
ESC Heart Fail; 2021 Oct; 8(5):3822-3834. PubMed ID: 34190418
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of controlling nutritional status in older adults with heart failure with preserved ejection fraction: a prospective comparative study with other objective nutritional indices.
Chen Y; Zheng H; He Y
Aging Clin Exp Res; 2023 Jun; 35(6):1305-1315. PubMed ID: 37005959
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
Li S; Li X
High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Importance of Right Ventricular-Vascular Uncoupling in Acute Decompensated Heart Failure With Preserved Ejection Fraction.
Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Abe H; Tamaki S; Yano M; Hayashi T; Nakagawa Y; Yamada T; Nakatani D; Hikoso S; Sakata Y
Circ Cardiovasc Imaging; 2020 Nov; 13(11):e011430. PubMed ID: 33198494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
